INDV-6001

· Indivior Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INDV-6001, covering 2026-03-16 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: INDV-6001 Multiple-Dose Pharmacokinetic Study [Phase 2]